Effects of landiolol hydrochloride on cardiohemodynamics in patients who underwent coronary artery bypass grafting

Japanese Journal of Anesthesiology

Volumn 54, Issue 4, 2005, Pages 402-407

  Iwasawa, Ken ^a   Nakagawa, Hideyuki ^a   Katou, Mikiyoshi ^a   Yonezawa, Kaori ^a   Nishizawa, Masaaki ^a   Yanagiya, Nobuyuki ^a  

^a NAGANO RED CROSS HOSPITAL   (Japan)

Author keywords

Heart rate; Landiolol hydrochloride; Negative chronotropic action

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FENTANYL; LANDIOLOL; MIDAZOLAM;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; BRADYCARDIA; CARDIOSELECTIVITY; CHRONOTROPISM; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEART HEMODYNAMICS; HEART INDEX; HEART STROKE VOLUME; HUMAN; INOTROPISM; LUNG VASCULAR RESISTANCE; MALE; SYSTEMIC VASCULAR RESISTANCE;

ADRENERGIC BETA-ANTAGONISTS; AGED; BLOOD PRESSURE; CENTRAL VENOUS PRESSURE; CORONARY ARTERY BYPASS; DEPRESSION, CHEMICAL; FEMALE; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MORPHOLINES; UREA; VASCULAR RESISTANCE;

EID: 17644424927     PISSN: 00214892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kertai MD, Bax JJ, Klein J, Poldermans D. Is there any reason to withhold beta blockers from high-risk patients with coronary artery disease during surgery? Anesthesiology 2004; 100: 4-7.
2. Salpeter SR, Ormiston TM, Salpeter EE. Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis. Ann Intern Med 2002; 137: 715-25.
3. Atarashi H, Kuruma A, Yashima M, Saitoh H, Ino T, Endoh Y, et al. Pharmacokinetics of landiolol hydrochloride, a new ultra-short-acting beta-blocker, in patients with cardiac arrhythmias. Clin Pharmacol Ther 2000; 68: 143-50.
4. Eagle KA, Berger PB, Calkins H, Bernard R, Ewy GA, Fleischmann KE, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery-Executive summary. Circulation 2002; 105: 1257-67.
5. Yasuda T, Kamiya H, Tanaka Y, Watanabe G. Ultra-short-acting cardioselective beta-blockade attenuates postischemic cardiac dysfunction in the isolated rat heart. Eur J Cardiothorac Surg 2001; 19: 647-52.
6. Takeo S, Yamada H, Tanonaka K, Hayashi M, Sunagawa N. Possible involvement of membrane-stabilizing action in beneficial effect of beta adrenoceptor blocking agents on hypoxic and posthypoxic myocardium. J Pharmacol Exp Ther 1990; 254: 847-56.
7. Muraki K, Nakagawa H, Nagano N, Henmi S, Kawasumi H, Nakanishi T, et al. Effects of ONO-1101, a novel beta-antagonist, on action potential and membrane currents in cardiac muscle. J Pharmacol Exp Ther 1996; 278: 555-63.
8. Spyrou N, Rosen SD, Fath-Ordoubadi F, Jagathesan R, Foale R, Kooner JS, et al. Myocardial beta-adrenoceptor density one month after acute myocardial infarction predicts left ventricular volumes at six months. J Am Coll Cardiol 2002; 40: 1216-24.
9. Anthonio RL, Brodde OE, van Veldhuisen DJ, Scholtens E, Crijns HJ, van Gilst WH. Beta-adrenoceptor density in chronic infarcted myocardium: a subtype specific decrease of beta 1-adrenoceptor density. Int J Cardiol 2000; 72: 137-41.
10. Kompa AR, Gu XH, Evans BA, Summers RJ. Desensitization of cardiac beta-adrenoceptor signaling with heart failure produced by myocardial infarction in the rat. Evidence for the role of Gi but not Gs or phosphorylating proteins. J Mol Cell Cardiol 1999; 31: 1185-201.
11. O'Donnell SR, Wanstall JC. Beta-1 and beta-2 adrenoceptor-mediated responses in preparations of pulmonary artery and aorta from young and aged rats. J Pharmacol Exp Ther 1984; 228: 733-8.